Results 11 to 20 of about 6,010,235 (261)

Hospital Infection Control in Hematopoietic Stem Cell Transplant Recipients

open access: yesEmerging Infectious Diseases, 2001
Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients contains a section on hospital infection control including evidence-based recommendations regarding ventilation, construction, equipment, plants, play ...
Clare A. Dykewicz
doaj   +2 more sources

Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study

open access: yesHematology, Transfusion and Cell Therapy, 2019
Background: ABO blood group incompatibility between donor and recipient is associated with a number of immunohematological complications, but is not considered a major contraindication to allogeneic hematopoietic stem cell transplantation.
José Alfreu Soares Júnior   +5 more
doaj   +2 more sources

Risk factors of bacterial infection after hematopoietic stem cell transplant.

open access: yes, 2022
Risk factors of bacterial infection after hematopoietic stem cell transplant.
Suradej Hongeng (285857)   +7 more
core   +2 more sources

Infectious outcomes after hematopoietic stem cell transplant.

open access: yes, 2022
Infectious outcomes after hematopoietic stem cell transplant.
Suradej Hongeng (285857)   +7 more
core   +1 more source

Caught in the antiviral crossfire: Ganciclovir-associated mutagenesis in HSC transplant recipients. [PDF]

open access: yes, 2021
In this issue of Cell Stem Cell, de Kanter et al. (2021) show that most allogeneic hematopoietic stem cells do not acquire additional somatic mutations following transplantation.
Nangalia, J, Spencer Chapman, M
core   +1 more source

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study [PDF]

open access: yes, 2013
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro   +31 more
core   +1 more source

Non-infectious outcomes after hematopoietic stem cell transplant.

open access: yes, 2022
Non-infectious outcomes after hematopoietic stem cell transplant.
Suradej Hongeng (285857)   +7 more
core   +1 more source

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients [PDF]

open access: yes, 2013
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients
Lehrnbecher, Thomas   +11 more
core   +1 more source

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor [PDF]

open access: yes, 2013
Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation.
Dembowsky, K.   +38 more
core   +1 more source

Identification of the niche and phenotype of the first human hematopoietic stem cells [PDF]

open access: yes, 2014
In various vertebrate species, the dorsal aorta (Ao) is the site of specification of adult hematopoietic stem cells (HSCs). It has been observed that the upregulation of essential hematopoietic transcription factors and the formation of specific intra ...
Stanislav Rybtsov   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy